by admin | Aug 20, 2024 | News & Opinions
By Technology Networks – Research offers new hope for treating neurodevelopmental disorders by activating dormant neural stem cells. Scientists from Duke-NUS Medical School and the Mechanobiology Institute (MBI) at the National University of Singapore (NUS) have...
by admin | Aug 19, 2024 | News & Opinions
By University of Louisville School of Medicine – A new stem cell therapy for heart failure is being tested in patients at the University of Louisville and UofL Health. The trial is the first in the U.S. to test umbilical cord-derived stem cells in patients for...
by admin | Aug 19, 2024 | News & Opinions
By University of Louisville School of Medicine – A new stem cell therapy for heart failure is being tested in patients at the University of Louisville and UofL Health. The trial is the first in the U.S. to test umbilical cord-derived stem cells in patients for...
by admin | Aug 16, 2024 | News & Opinions
By Natalie Healey – Nature Medicine Going from the laboratory to an approved therapy in 11 years is no mean feat. That is the story of the world’s first approved CRISPR–Cas9 therapy, greenlit by the US Food and Drug Administration in December 2023. Casgevy...
by admin | Aug 15, 2024 | News & Opinions
By Inside Precision Medicine – The immunotherapy afamitresgene autoleucel (afami-cel) for the treatment of adults with the rare soft tissue cancer called synovial sarcoma was granted accelerated approval late last week by the U.S. Food and Drug Administration...
by admin | Aug 14, 2024 | News & Opinions
By University of Barcelona – A study published in The EMBO Journal opens new perspectives to better understand how the molecular mechanisms involved in regenerative medicine work. The study focuses on tumour necrosis factor-α (TNF-α) and its receptors TNFR,...
